-+ 0.00%
-+ 0.00%
-+ 0.00%

CLENE INC: FDA CONFIRMS ALS SURVIVAL DATA TYPE C MEETING & END-OF-PHASE 2 TYPE B MS PROGRAM MEETING FOR Q3 2025

Reuters·06/30/2025 12:15:06

Please log in to view news